Cooper Companies Reports Q2 Net Loss Driven by $271.6M Litigation Charge; Extends $950M Term Loan
Summary
Cooper Companies reported a Q2 net loss of $77.9 million and an operating loss of $31.0 million, primarily due to a $271.6 million litigation accrual in its CooperSurgical segment, despite a 7.9% increase in net sales. The company also extended $950 million in term loan maturities.
Key Events
-
Q2 Net Loss Reported
The company reported a net loss of $77.9 million for the three months ended April 30, 2026, a significant decline from a net income of $87.7 million in the prior-year period. Diluted EPS was $(0.40) compared to $0.44 previously.
-
Major Litigation Accrual
A net litigation expense of $271.6 million was recorded in the CooperSurgical segment, consisting of a $324.1 million accrued liability partially offset by $52.5 million in insurance recoveries. This charge was the primary driver of the Q2 operating and net losses.
-
Revenue Growth Continues
Net sales increased by 7.9% to $1,081.5 million for Q2 2026, up from $1,002.3 million in Q2 2025. CooperVision net sales grew 8% and CooperSurgical net sales grew 8%.
-
Term Loan Maturity Extended
$950.0 million of term loans under the 2021 Credit Agreement had their maturity date extended to February 3, 2031, improving the company's long-term debt profile.
Analysis
Cooper Companies reported a significant net loss and operating loss for Q2 2026, primarily due to a $271.6 million litigation expense related to its CooperSurgical segment. This charge overshadowed solid revenue growth in both CooperVision and CooperSurgical segments. While the company successfully extended $950 million of term loan maturities, the substantial litigation accrual represents a material financial hit that impacted profitability and working capital.
At the time of this filing, COO was trading at $66.90 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $13.1B. The 52-week trading range was $58.89 to $89.83. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.